NOVT
Price Action
Structure is constructive on both timeframes without excessive extension — a reasonable entry location.
Key Financials
- Market Cap
- $5.1B
- Avg Volume (60D)
- 406.8K
- Revenue Growth YoY
- +3.3%
- Gross Margin
- +44.5%
- Operating Margin
- +9.0%
- Free Cash Flow Yield
- +2.2%
- Distance from 200DMA
- -5.1%
- Next Earnings
- 2026-11-09
- P/E
- 82.8x
- EV / EBITDA
- 30.0x
- EV / Sales
- 4.5x
Business Performance
MixedRevenue is growing at a steady pace (+10% year over year). Reported earnings improved faster than operating income, so most of the improvement did not come from operations.
- +1.4%
- +8.5%
- +10%
- +10%
- -43%
- -2.2%
- -14%
- +150%
Business Quality
8.0 / 10How well the business earns on its assets, converts earnings to cash and funds itself — read from its SEC filings.
Fundamentals & Valuation
Company Research
Economic classification
Business & Markets
Novanta Inc. designs, manufactures, and supplies precision components and systems for medical, industrial, and robotics applications through its Automation Enabling Technologies and Medical Solutions segments.
The company generates revenue primarily through transactional sales of precision hardware and integrated solutions to OEMs and end customers.
Niche leader in precision robotics components and medical technology solutions.
Demand tied to capital spending cycles in medical and advanced industrial manufacturing sectors.